ArticleBrain and behavior2025
Insulin Resistance and Cognitive Function in Nondiabetic Patients With Cerebral Small Vessel Disease: Role of Brain Glymphatic Function.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Insulin resistance-related metabolic burden, white matter microstructure, and cognitive change: the HABS-HD study.Frontiers in neuroscience · 2026Article
- Insulin Resistance and Cognitive Function in Nondiabetic Patients With Cerebral Small Vessel Disease: Role of Brain Glymphatic Function.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveBoth insulin sensitivity and brain glymphatic function were linked to cognitive function in nondiabetic patients with cerebral small vessel disease (CSVD). This study aims to elucidate these complex associations through mediation analysis.
methodsPatients who underwent multimodal magnetic resonance imaging (MRI) scans were recruited. Global cognitive assessment was performed by Mini-Mental State Examination (MMSE), four isolated cognitive domains were assessed simultaneously. Glymphatic function was assessed using the diffusion tensor imaging along the perivascular space (DTI-ALPS) index, insulin sensitivity was assessed by the homeostasis model assessment-estimated insulin resistance index (HOMA-IR), and HOMA-IR≥2.80 was defined as insulin resistance (IR). Mediation analysis was conducted to examine the effect of the DTI-ALPS on insulin sensitivity and cognitive function.
results110 CSVD patients were recruited, 40 patients were IR and 70 patients were non-IR. Both the HOMA-IR and DTI-ALPS index were significant predictors of cognitive function, with B = -0.592, 95%CI, -0.939 to -0.244, p = 0.001 and B = 9.378, 95% CI, 3.376 to 15.381, p = 0.003, respectively, after adjusting for age, sex, and other confounding factors. Mediation analysis revealed that the DTI-ALPS index served as a significant partial mediator in the relationship between HOMA-IR and cognitive function, with direct effect = -0.649 (95% CI, -1.015 to -0.282, p < 0.001), total effect = -0.743 (95% CI, -1.106 to -0.380, p < 0.001), and the indirect effect = -0.094 (95% CI, -0.236 to -0.006, p = 0.029), accounting for 12.66% of the total effect.
conclusionBoth the HOMA-IR and the DTI-ALPS index are independent risk factors for cognitive function. Furthermore, the DTI-ALPS index significantly and partially mediates the relationship between the HOMA-IR and cognitive function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.